Companies:
51,108
Total Market Cap:
153097401278855.33
FibroGen
NASDAQ: FGEN
Healthcare
Biotechnology
Global Rank
#32760
Country Rank
#4441
Market Cap
37.2 M
Price
9.2
Change (%)
0.77%
Volume
315
FibroGen's latest marketcap:
37.2 M
As of 11/13/2025, FibroGen's market capitalization has reached $37.2 M. According to our data, FibroGen is the 32760th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 37.2 M |
| Revenue (ttm) | 8.3 M |
| Net Income (ttm) | 215.65 M |
| Shares Out | 4.04 M |
| EPS (ttm) | 53.38 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 11/10/2025 |
Market Cap Chart
Data Updated: 11/13/2025
FibroGen's yearly market capitalization.
FibroGen has seen its market value drop from $1.52 B to $37.2 M since 2014, representing a total decrease of 97.56% and an annual compound decline rate (CAGR) of 28.92%.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 11/13/2025 | $37.2 M | -16.67% | 32760 |
| 12/31/2024 | $53.4 M | -38.76% | 27559 |
| 12/29/2023 | $87.2 M | -94.21% | 24000 |
| 12/30/2022 | $1.51 B | 15.15% | 6434 |
| 12/31/2021 | $1.31 B | -61.28% | 7950 |
| 12/31/2020 | $3.38 B | -9.8% | 3817 |
| 12/31/2019 | $3.74 B | -4.85% | 2975 |
| 12/31/2018 | $3.93 B | 1.17% | 2465 |
| 12/29/2017 | $3.89 B | 187.6% | 2837 |
| 12/30/2016 | $1.35 B | -27.68% | 5260 |
Company Profile
FibroGen was founded in 1993 in United States.
The company went public on 11/14/2014
on the Nasdaq Stock Market.
With 225 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.
Frequently Asked Questions
-
What is FibroGen's (FGEN) current market cap?As of 11/13/2025, FibroGen (including the parent company, if applicable) has an estimated market capitalization of $37.2 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does FibroGen (FGEN) rank globally by market cap?FibroGen global market capitalization ranking is approximately 32760 as of 11/13/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.